INTRODUCTION
Spermatocytic seminoma (SS) is a special form of germ cell tumors that different from the classical seminoma, with generally occurs in older (>50 years) and younger (<30 years) males (1) . There is no ovarian carcinoma that may be the equivalent of SS and it is not associated with another testicular tumors, nor is it associated with cryptorchidism (2) . Accor-ding the different series, SS represents between 2% and 12% of all seminoma patients (3) . Masson described the first case of SS at 50 years ago, and just about 400 cases, most of them benign, have been reported in the literature (3, 4) . It is a solid tumor with excellent prognosis that does not appear prominent in the early stage and does not metastasize (4) . SS occurs more frequently in the right testis and shows higher bilaterality than the classical seminoma (4, 5) . We report in this case a SS in a 55-year-old male along with a review of literature and attention to histological and clinical characteristics.
CASE REPORT
A 55-year-old male patient presented with a painless, slowly enlarging right testicular mass of 1 year was admitted to the urology polyclinic. There was no history of scrotal pain, cryptorchidism or trauma in this patient. Unilateral testicular growth was seen on physical examination. In the palpation, a welldefined, hard, painless right testicle mass was detected and inguinal lymph node was not observed. Ultrasonography showed a 7x5 cm sized solid tumor with heterogeneous echogenicity. No features were seen on computed tomography. Tumor markers as alpha-fetoprotein, lactate dehydrogenase and beta human chorionic gonadotropin were in normal range. On macroscopic examination, a 7x5 cm sized, subcapsular localized, well-defined, yellow-brownish paled, clearly separated tumoral lesion was observed. Tunica vaginalis, tunica albuginea and skin were not invasived. Histological examination revealed that the tumor showed a diffuse pattern in a mucinous intermediate substance Representative examples of hematoxylin and eosin (H&E) and placenta-like alkaline phosphatase (PLAP) with spermatocytic seminoma (SS) (Figure) .
DISCUSSION
SS is different testicular tumors first described in 1946 by Masson (4) . SS has a separate pathogenic pathway and the prognosis is much better than the classical seminoma (5) . Along with publications in the literature indicating that the incidence of spermatocytic seminomas ranges between 1.7% and 12% of all seminomas and most of large studies have a frequency between 1.1% and 7.4% (5, 6) . For example, spermatocytic seminomas were detected in 58 of the 9,658 malignant testicular tumors in Australian cancer registry, with an incidence rate of less than 1.1% of all seminomas (6) .
Being more usually in elderly patients, has no ovarian counterpart, occurs only in descended testis, and has never been found at extragonadal sites without involvement of testis are differences of SS from the classical seminoma (7) . It originates from the different cell of classical seminoma because of finding SCP1 and XPA proteins that are normally expressed in premeiotic germ cells. Presence of chromosome 9 is not found in classical seminomas and is a consistent evidence in all of the SS patients (7) . Most SS cases are found in a painless, slowly growing mass that can be palpated on the testis. The SS is usually seen in the sixth decade of old white males. Chung et al. (8) reported that the mean age was 62 years old (range from 32-77 years) and Raiss et al. (9) found that the median age was 45 years. Macroscopically, it is always seen as a homogeneous, well-limited tumor confined to the testicle and occurs a testicular mass with ranging between 1.5 and 28 cm (8, 9) .
Spermatocytic seminoma is morphologically characterized by the arrangement of a mixture of three distinct measured cells resembling spermatogonia and spermatocytes in layers and cords. They usually have a typical spermatocyte chromatin distribution. The nucleus of SS cell has a slightly oval or round shaped, smooth contour, as distinct to nuclei of classical seminoma cells (10) . Immunohistochemically, PLAP is stained negative as a characteristic feature of this tumor, whereas classical seminoma are always stained positive. Generally, SS cells show focal or weak c-kit positivity, although there are different opinions in the literature. Another markers such as neuroendocrine markers, lymphoid markers and cytokeratin have been reported to be negative (11) . The histologic and clinical features of our case are compatible with the information described in the literature.
Anaplastic variant of SS is the other important histological feature. Up to now, only six cases have been reported that define this variation (11) . This uncommon variant is characterized by features such as multiple mitosis, extensive necrosis and invasion to surrounding tissues. Nevertheless, this component does not affect the good prognosis of SS. Only three metastatic described cases as proven showed that SS have to very low malignant potential (12) . When the case is associated with sarcomatous component, metastatic disease has been reported. The component of sarcoma is generally high-grade undifferentiated sarcoma or a rhabdomyosarcoma and the metastatic disease usually develops from this sarcomatous component. Reports of sarcomatous differentiation in SS have been associated with poor prognosis and aggressive behavior (12) . We have not detected recurrent metastases in our 3 year follow-up.
Consequently, SS is an indolent germ cell tumors rarely metastasizing and having a good prognosis although sporadic metastatic SS cases have been reported. For this reason, only orchiectomy is indicated for treatment. However, in the case of sarcomatous differentiation, aggressive behavior or metastasis may occur (13) . In these cases radiotherapy and adjuvant chemotherapy may be useful.
RESULT
Spermatocytic seminoma is a unusual testicular germ cell tumors. Almost entirely benign viewing shows a marked difference in behavior from the classical seminoma. All cases should be followed because of rare metastatic events. Because the majority of cases have surgery sufficient, it is significant to remind this rare tumor especially in elderly cases.
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